» Articles » PMID: 36986397

Spatial Distribution of Drug-Resistant Infections in Rural Eastern Cape Province of South Africa

Overview
Journal Pathogens
Date 2023 Mar 29
PMID 36986397
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis (TB), an infectious airborne disease caused by (Mtb), is a serious public health threat reported as the leading cause of morbidity and mortality worldwide. South Africa is a high-TB-burden country with TB being the highest infectious disease killer. This study investigated the distribution of Mtb mutations and spoligotypes in rural Eastern Cape Province. The Mtb isolates included were 1157 from DR-TB patients and analysed by LPA followed by spoligotyping of 441 isolates. The distribution of mutations and spoligotypes was done by spatial analysis. The gene had the highest number of mutations. The distribution of and mutations was more prevalent in four healthcare facilities, mutations were more prevalent in three healthcare facilities, and heteroresistant isolates were more prevalent in five healthcare facilities. The Mtb was genetically diverse with Beijing more prevalent and largely distributed. Spatial analysis and mapping of gene mutations and spoligotypes revealed a better picture of distribution.

Citing Articles

The PHA4GE Microbial Data-Sharing Accord: establishing baseline consensus microbial data-sharing norms to facilitate cross-sectoral collaboration.

Griffiths E, van Heusden P, Tamuhla T, Lulamba E, Bedeker A, Nichols M BMJ Glob Health. 2024; 9(10).

PMID: 39477336 PMC: 11529761. DOI: 10.1136/bmjgh-2024-016474.


Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa.

Gounder L, Khan A, Manasa J, Lessells R, Tomita A, Pillay M Viruses. 2024; 16(10).

PMID: 39459966 PMC: 11512327. DOI: 10.3390/v16101634.


Collaborative learning in the digital age: empowering tuberculosis researchers through virtual training.

Dippenaar A, Sylvester T, Ealand C, Ismail N, Rakotosamimanana N, Miller M J Microbiol Biol Educ. 2024; 25(3):e0011424.

PMID: 39258916 PMC: 11636240. DOI: 10.1128/jmbe.00114-24.


Current Treatment of Drug-Resistant Tuberculosis in Children.

Schaaf H, Hughes J Indian J Pediatr. 2023; 91(8):806-816.

PMID: 37995068 PMC: 11249413. DOI: 10.1007/s12098-023-04888-z.


Treatment Outcomes and Associated Factors among Tuberculosis Patients from Selected Rural Eastern Cape Hospitals: An Ambidirectional Study.

Faye L, Hosu M, Iruedo J, Vasaikar S, Nokoyo K, Tsuro U Trop Med Infect Dis. 2023; 8(6).

PMID: 37368733 PMC: 10300936. DOI: 10.3390/tropicalmed8060315.

References
1.
Alene K, Xu Z, Bai L, Yi H, Tan Y, Gray D . Spatial clustering of drug-resistant tuberculosis in Hunan province, China: an ecological study. BMJ Open. 2021; 11(4):e043685. PMC: 8021748. DOI: 10.1136/bmjopen-2020-043685. View

2.
Thwaites G, Caws M, Chau T, DSa A, Lan N, Huyen M . Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol. 2008; 46(4):1363-8. PMC: 2292951. DOI: 10.1128/JCM.02180-07. View

3.
Maguga-Phasha N, Munyai N, Mashinya F, Makgatho M, Mbajiorgu E . Genetic diversity and distribution of Mycobacterium tuberculosis genotypes in Limpopo, South Africa. BMC Infect Dis. 2017; 17(1):764. PMC: 5727936. DOI: 10.1186/s12879-017-2881-z. View

4.
Van Rie A, Victor T, Richardson M, Johnson R, van der Spuy G, Murray E . Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005; 172(5):636-42. PMC: 2718533. DOI: 10.1164/rccm.200503-449OC. View

5.
Rigouts L, Miotto P, Schats M, Lempens P, Cabibbe A, Galbiati S . Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations. Sci Rep. 2019; 9(1):11760. PMC: 6692311. DOI: 10.1038/s41598-019-48289-9. View